GSK Plc (GSK)
56.69
+0.70
(+1.25%)
USD |
NYSE |
Apr 02, 16:00
56.69
0.00 (0.00%)
Pre-Market: 20:00
GSK Market Cap : 114.82B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 319.57B |
| Biodexa Pharmaceuticals Plc | 14.15M |
| Novavax, Inc. | 1.208B |
| Mereo BioPharma Group Plc | 49.34M |
| BioNTech SE | 23.41B |
Market Cap Related Metrics
| PE Ratio | 15.47 |
| PS Ratio | 2.701 |
| PEG Ratio | 0.1176 |
| Price to Book Value | 5.143 |
| Price to Free Cash Flow | 20.39 |
| Price | 56.69 |
| Earnings Yield | 6.46% |
| PEGY Ratio | 0.1149 |
| Operating PE Ratio | 11.97 |
| Normalized PE Ratio | 14.33 |